UNSPSC 51191580: Prorenoate potassium

This classification denotes a potassium-sparing diuretic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T2D4XUS623. European Medicines Agency schedules Prorenoate potassium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10129MIG.

Prorenoate potassium generally arises in the molecular formula C23H31O4.K. The term PRORENOATE POTASSIUM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 29, no. 10 1975, list 15.) Most nations, for tariff and trade purposes, schedule prorenoate potassium under HS 29372900 and SITC 54153. As of Q4 2014, PRORENOATE POTASSIUM remains US FDA's Preferred Term for this commodity. Prorenoate potassium bears US NLM identifiers UMLS ID C0072213 and NCI Concept Code C84118.

UNSPSC 51191580 Prorenoate potassium is a Commodity code that in practice captures chemical and pharmaceutical supply for state and local government operations, particularly water treatment facilities and multi-state cooperative health procurement. Recent solicitations show the code drawing bids for chemical commodities used in municipal water pollution control and for generic pharmaceuticals and over-the-counter products distributed through state and local health systems. Issuing bodies include city-level water utilities and multi-state cooperative purchasing alliances administered by state procurement offices, suggesting both single-jurisdiction municipal buyers and coordinated multi-jurisdiction health procurement vehicles participate under this code.

The City of Meriden, Connecticut issued an IFB (Solicitation B027-15) on July 8, 2026 for sodium bisulfite chemical supply to its Water Pollution Control Facility, with bids due July 29, 2026 and requiring performance and payment bonds plus specified insurance coverage. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) posted January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline, establishing multi-award contracts effective July 1, 2026 for distribution across participating state and local government facilities including Oregon. Recent activity spans Connecticut and multi-state cooperative systems anchored in Minnesota, with the code capturing both municipal chemical procurement and coordinated pharmaceutical supply chains that require cGMP certification, DSCSA compliance, and authorized-wholesaler distribution relationships.